Annual Cash & Cash Equivalents
$5.26B$298.00M-5.36%
Summary
- Current Value
- As of today, ABBV annual cash & cash equivalents is $5.26B, down -5.36% on
- Historical Performance
- ABBV annual cash & cash equivalents is down -43.04% over the past 3 years, down -38.00% over the past 5 years
- All-Time High Comparison
- ABBV annual cash & cash equivalents is currently -86.83% below its historical high of $39.92B set on
- 3-Year Low Comparison
- ABBV annual cash & cash equivalents is at its 3-year low
- Sector Comparison
- ABBV annual cash & cash equivalents is higher than 97.93% of companies in Healthcare sector
Cash and Cash Equivalents Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $5.26B | -5.4% | -43.0% | -38.0% | +179.1% | |
| Quarterly Cash & Cash Equivalents | $9.39B | +81.4% | +39.7% | -4.0% | – | |
| Price | $227.23 | +21.2% | +66.0% | +102.2% | – | |
| Annual Current Assets | $29.06B | +13.6% | +2.1% | +20.2% | +253.6% | |
| Annual Total Liabilities | $137.19B | +4.1% | +12.9% | -0.2% | +2425.7% | |
| Annual Working Capital | -$14.23B | -8.1% | -1223.4% | -217.0% | -419.2% | |
| Annual Net Income | $4.19B | -1.3% | -64.4% | -8.1% | +0.4% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $12.82B | -59.0% | |
| 5Y | $12.82B | -59.0% | |
| All | $39.92B | -86.8% |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $5.26B | at low | |
| 5Y | $5.26B | at low | |
| All | $653.58M | +704.3% |
Cash and Cash Equivalents History
FAQ
What is the current annual cash & cash equivalents of ABBV?
As of today, ABBV annual cash & cash equivalents is $5.26B
What is 1-year change in ABBV annual cash & cash equivalents?
ABBV annual cash & cash equivalents is down -5.36% year-over-year
What is 3-year change in ABBV annual cash & cash equivalents?
ABBV annual cash & cash equivalents is down -43.04% over the past 3 years
How far is ABBV annual cash & cash equivalents from its all-time high?
ABBV annual cash & cash equivalents is currently -86.83% below its historical high of $39.92B set on December 31, 2019
How does ABBV annual cash & cash equivalents rank versus sector peers?
ABBV annual cash & cash equivalents is higher than 97.93% of companies in Healthcare sector
When is ABBV next annual earnings release?
As of today, the next annual earnings release for ABBV has not been scheduled
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Quarterly Cash & Cash Equivalents
$9.39B$4.13B+78.64%
Summary
- Current Value
- As of today, ABBV quarterly cash & cash equivalents is $9.39B, up +78.64% on
- Historical Performance
- ABBV quarterly cash & cash equivalents is up +81.43% year-over-year, up +39.71% over the past 3 years
- All-Time High Comparison
- ABBV quarterly cash & cash equivalents is currently -77.17% below its historical high of $41.14B set on
- 3-Year Low Comparison
- ABBV quarterly cash & cash equivalents is +81.43% above its 3-year low of $5.18B reached on
- Sector Comparison
- ABBV quarterly cash & cash equivalents is higher than 99.13% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $9.39B | +78.6% | +81.4% | +39.7% | -4.0% | |
| Annual Cash & Cash Equivalents | $5.26B | – | -5.4% | -43.0% | -38.0% | |
| Price | $227.23 | -2.2% | +21.2% | +66.0% | +102.2% | |
| Quarterly Current Assets | $33.53B | +15.4% | +21.1% | +26.6% | +26.2% | |
| Quarterly Total Liabilities | $143.08B | +4.3% | +6.2% | +18.0% | +4.6% | |
| Quarterly Working Capital | -$8.57B | +39.8% | +1.8% | -677.8% | -59.3% | |
| Quarterly Net Income | $687.00M | -61.9% | -46.3% | +198.7% | -80.5% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $9.39B | at high | |
| 3Y | $18.07B | -48.0% | |
| 5Y | $18.07B | -48.0% | |
| All | $41.14B | -77.2% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $5.18B | N/A | +81.4% |
| 3Y | $5.18B | +81.4% | |
| 5Y | $5.18B | +81.4% | |
| All | $42.99M | >+9999.0% |
Quarterly Cash & Cash Equivalents History
FAQ
What is the current quarterly cash & cash equivalents of ABBV?
As of today, ABBV quarterly cash & cash equivalents is $9.39B
What is ABBV quarterly cash & cash equivalents most recent change?
ABBV quarterly cash & cash equivalents was up +78.64% on March 31, 2026
What is 1-year change in ABBV quarterly cash & cash equivalents?
ABBV quarterly cash & cash equivalents is up +81.43% year-over-year
How far is ABBV quarterly cash & cash equivalents from its all-time high?
ABBV quarterly cash & cash equivalents is currently -77.17% below its historical high of $41.14B set on March 31, 2020
How does ABBV quarterly cash & cash equivalents rank versus sector peers?
ABBV quarterly cash & cash equivalents is higher than 99.13% of companies in Healthcare sector
When is ABBV next earnings release?
The next earnings release for ABBV is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- ABBV Official Website www.abbvie.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1551152/000155115226000008/0001551152-26-000008-index.htm
- ABBV Profile on Yahoo Finance finance.yahoo.com/quote/ABBV
- ABBV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/abbv